Skip to main content
logo
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.67
+0.27 (4.22%)
At close: Aug 7, 2026, 4:00 PM EDT
6.70
+0.03 (0.45%)
After-hours: Aug 7, 2026, 7:34 PM EDT

Gyre Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7076451,0441,96850629
Market Cap Growth
11.13%-38.27%-46.93%289.25%1669.60%-79.48%
Enterprise Value
635.87629.441,0542,029510.66-15.9
Last Close Price
6.677.0612.1025.697.9513.65
PE Ratio
-353.00242.00-265.0056.88
Forward PE
-32.84----
PS Ratio
6.445.539.8717.344.943.89
PB Ratio
6.556.0816.49-124.3211.890.70
P/TBV Ratio
5.137.1919.63-14.2522.16
P/FCF Ratio
---113.2588.81-
P/OCF Ratio
-638.29-76.0047.35-
EV/Sales Ratio
5.795.409.9717.884.99-2.17
EV/EBITDA Ratio
-45.0659.53-49.630.18
EV/EBIT Ratio
-54.8065.23-55.490.18
EV/FCF Ratio
---116.7789.720.19
Debt / Equity Ratio
0.010.000.010.010.000.01
Debt / EBITDA Ratio
-0.070.09-0.06-
Debt / FCF Ratio
---0.020.11-
Net Debt / Equity Ratio
-0.55-0.49-0.402.09-0.58-1.08
Net Debt / EBITDA Ratio
5.40-3.69-1.420.50-2.390.51
Net Debt / FCF Ratio
3.48286.034.21-1.90-4.320.53
Asset Turnover
0.650.800.871.131.460.10
Inventory Turnover
--1.810.891.57-
Quick Ratio
3.594.892.862.513.463.44
Current Ratio
4.265.603.322.854.063.63
Return on Equity (ROE)
-10.02%8.21%31.86%-198.41%7.61%-150.11%
Return on Assets (ROA)
-11.08%5.39%10.30%-74.19%6.01%-116.80%
Return on Invested Capital (ROIC)
-25.45%9.58%46.00%-523.91%19.05%-
Return on Capital Employed (ROCE)
-10.47%9.05%15.97%-79.56%16.14%-148.28%
Earnings Yield
-0.28%0.41%-0.38%1.76%
FCF Yield
---0.88%1.13%-
Buyback Yield / Dilution
1.16%-0.87%-55.39%13.02%-13.45%-5117.44%
Total Shareholder Return
1.16%-0.87%-55.39%13.02%-13.45%-5117.44%
SEC Filings: 10-K · 10-Q